Hematologists Accepting Cigna in OregonPage 2

Ian Schnadig, M.D.

Medical Oncology

Hematology

Mark Stone, M.D.

Hematology Oncology

Hematology

Edward Chang, M.D.

Medical Oncology

Hematology

Joseph Shatzel, M.D.

Assistant Professor of Medicine and Biomedical Engineering

Hematology

Rachel Sanborn, MD

Medical Director, Thoracic Oncology Program; Medical Director, Phase I Clinical Trials Program, Earle A. Chiles Research Institute, Providence Cancer Institute

Hematology

John Strother, M.D

Hematology

Eric Roeland, MD

Associate Professor of Medicine

Hematology

Kevin Yee, M.D.

Assistant Professor of Hematology and Oncology

Hematology

Mujahid Rizvi, MD

Hematology

Zheng Topp, M.D.

Medical Oncology

Hematology

Hagen Kennecke, MD, MHA, FRCPC

Section Chief and Chief Health Officer, OHSU Knight-Legacy Health Cancer Collaborative

Hematology

Janelle Meyer, MD

Hematology

Stacy Lewis, MD

Medical Oncology

Hematology

Glenn Buchanan, MD

Hematology

Ronald Ng, MD

Hematology

Shivaani Kummar, MD

Associate Chief Executive Officer, OHSU Knight Cancer Institute, School of Medicine; Margaret and Lester DeArmond University Chair of Molecular Oncology, Division of Hematology/Medical Oncology, School of Medicine; Co-Director, Center for Experimental Therapeutics, Knight Cancer Institute

Hematology

Erin Nelli, D.O.

Hematology Oncology

Hematology

Merav Sendowski, MD

Adjunct Assistant Professor of Medicine

Hematology

Amrita Desai, M.D.

Hematologist/Oncologist, Center for Hematologic Malignancies

Hematology

Ashley Shubert, MD

Hematology Oncology

Hematology